CCL2 and neoplasm: In this study, a subset of iCAFs that expresses high levels of the chemokine CCL2, known as ICAM1+ iCAFs, was identified and was found to recruit MDSCs (THBS1+ monocytes) to hypoxic tumor areas by binding to the receptor CCR2.